GELNIQUE™ (Oxybutynin Chloride) 10% Gel Proved To Be An Effective, Safe Option For Female Overactive Bladder (OAB) Patients

Data to be presented at the American Urological Association’s (AUA) Annual Conference show that GELNIQUE™ (oxybutynin chloride) 10% gel significantly improves symptoms of OAB and urinary urge incontinence in women with the condition. By the end of the 12-week study period, 27 percent of women treated with GELNIQUE achieved complete urinary continence versus 15.6 percent treated with placebo. There were no treatment-related serious adverse events.


Read more

Related posts

Leave a Reply